Bladder Cancer and Chemical Carcinogens
Bladder cancer is the sixth most common cancer, with occupational and environmental chemical exposures playing established roles. Because PFAS are excreted through urine and concentrate in the bladder, urothelial exposure to PFAS may be particularly significant.
Urothelial PFAS Concentration Mechanism
Renal tubular reabsorption of PFAS followed by urinary excretion concentrates these compounds in bladder urine. The urothelium—the epithelial lining of the bladder—thus faces prolonged exposure to concentrated PFAS beyond systemic blood levels.
Carcinogenesis Evidence
Animal studies show PFAS compounds promote urothelial cell proliferation and inhibit apoptosis. Epidemiological studies of workers occupationally exposed to fluorochemicals show elevated bladder cancer incidence ratios in multiple cohorts.
Clinical Vigilance
Urologists managing patients with hematuria in PFAS-affected regions should maintain heightened suspicion for bladder cancer. Cystoscopy and urine cytology thresholds may warrant lowering for high-exposure populations.